Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review
@article{Luime2010DoesAC, title={Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review}, author={J. Luime and E. Colin and J. Hazes and E. Lubberts}, journal={Annals of the Rheumatic Diseases}, year={2010}, volume={69}, pages={337 - 344} }
Objective: To review the diagnostic and prognostic value of anti-mutated citrullinated vimentin (MCV) in rheumatoid arthritis, taking into account the already available serology. Methods: Medline was searched via PubMed (1966 to May 2008) for anti-MCV and related terms, arthritis and arthropathies. Studies with anti-MCV, arthritis/arthropathy, and primary data on diagnosis and/or prognosis were included. Their methodological quality was assessed using the Quality Assessment of Diagnostic… CONTINUE READING
Topics from this paper
Paper Mentions
Observational Clinical Trial
The aim of this work is to evaluate the diagnostic value of anti-MCV antibodies in rheamatoid
arthritis patients and to correlate its relationtion disease activity and manifestations… Expand
Conditions | Anti-MCV in Rheamatoid Arthritis |
---|---|
Intervention | Diagnostic Test |
74 Citations
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study
- Medicine
- Annals of the rheumatic diseases
- 2010
- 122
- PDF
Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
- Medicine
- Clinical chemistry and laboratory medicine
- 2019
- 7
- PDF
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
- Medicine
- Autoimmunity reviews
- 2012
- 51
- Highly Influenced
- PDF
Anti-Mutated Citrullinated Vimentin (Anti-MCV) Antibodies as a Diagnostic Aid for Rheumatoid Arthritis
- Medicine
- 2014
- 3
- PDF
Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
- Medicine
- Clinical and experimental rheumatology
- 2011
- 27
Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis
- Medicine
- Clinical Rheumatology
- 2016
- 9
Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis
- Medicine
- Modern rheumatology
- 2019
- 1
- PDF
Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
- Medicine
- Clinical medicine insights. Arthritis and musculoskeletal disorders
- 2010
- 24
- PDF
References
SHOWING 1-10 OF 77 REFERENCES
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
- Medicine
- Arthritis and rheumatism
- 2008
- 208
Antibodies to Citrullinated Vimentin are a Specific and Sensitive Marker for the Diagnosis of Rheumatoid Arthritis
- Medicine
- Clinical reviews in allergy & immunology
- 2008
- 65
Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
- Medicine
- The Journal of rheumatology
- 2007
- 84
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
- Medicine
- Arthritis and rheumatism
- 2007
- 278
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
- Medicine
- Arthritis research & therapy
- 2006
- 134
Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis
- Medicine
- Rheumatology International
- 2008
- 42
Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
- Medicine
- The Journal of rheumatology
- 2008
- 112
- Highly Influential
- PDF
Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis.
- Medicine
- The Journal of rheumatology
- 2006
- 31
Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
- Medicine
- Arthritis research & therapy
- 2008
- 85
- Highly Influential